{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3630, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/FIHWvTpQQk96S2DtYsWtX8vfyz6dDJTa_m-oKt_JMjg/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZGZiYzMzYzJhZjhiYmRhMGJlZTViYmJjMGViOTYzOC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/1", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "6c3da759-9ebe-4162-9416-8efc4c08e0cb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The initial slides provide context and disclaimers, setting the stage for the presentation.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/eSiQNOnWIqPLiq9UqCg1HKR-xMWC9aq9PLAMuvuQ0N4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZGZiYzMzYzJhZjhiYmRhMGJlZTViYmJjMGViOTYzOC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/ivh8c2Mr3vJmEe2CFBF0EBONS6hO2bqqy9oeYtOmfWU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZGZiYzMzYzJhZjhiYmRhMGJlZTViYmJjMGViOTYzOC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/PMidSbIrpK6OZ2aq_iJHeD-686SAkdKzlQO6e-Ycn4I/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZGZiYzMzYzJhZjhiYmRhMGJlZTViYmJjMGViOTYzOC9wMDAxLnBuZw" }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/2", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "6c3da759-9ebe-4162-9416-8efc4c08e0cb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The initial slides provide context and disclaimers, setting the stage for the presentation.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 3, "slideType": "other", "function": "establish_context", "notes": "The slide uses a three-column structure to define the firm's identity through Employee DNA, Firm's DNA, and Ownership/Controls.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/3", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "6c3da759-9ebe-4162-9416-8efc4c08e0cb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The initial slides provide context and disclaimers, setting the stage for the presentation.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 4, "slideType": "context", "function": "establish_context", "notes": "Slide highlights firm capabilities and scale.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/4", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "6c3da759-9ebe-4162-9416-8efc4c08e0cb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The initial slides provide context and disclaimers, setting the stage for the presentation.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 5, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a hub-and-spoke layout with the company logo at the center.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/5", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-5", "loopMatches": [ { "to": 9, "from": 5, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "77bdeb59-c138-4684-8515-17641ffd9b94", "evidence": "The golden circle loop is visible in slides 5-9, which focus on the company's investment tenets and market leadership.", "position": 0, "objective": "Why Houlihan Lokey's investment tenets matter", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "d0a554b2-3beb-4658-be5c-e2d7fd1b9f1a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slides 5-9 highlight the company's investment tenets, traction, and market leadership.", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 6, "slideType": "traction", "function": "show_traction", "notes": "Includes a background map graphic and specific footnotes regarding non-GAAP measures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/6", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-6", "loopMatches": [ { "to": 9, "from": 5, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "77bdeb59-c138-4684-8515-17641ffd9b94", "evidence": "The golden circle loop is visible in slides 5-9, which focus on the company's investment tenets and market leadership.", "position": 0, "objective": "Why Houlihan Lokey's investment tenets matter", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "d0a554b2-3beb-4658-be5c-e2d7fd1b9f1a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slides 5-9 highlight the company's investment tenets, traction, and market leadership.", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 7, "slideType": "team_bio", "function": "summarize", "notes": "The slide uses a split layout: left side for leadership headshots, right side for numbered list of cultural attributes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/7", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-7", "loopMatches": [ { "to": 9, "from": 5, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "77bdeb59-c138-4684-8515-17641ffd9b94", "evidence": "The golden circle loop is visible in slides 5-9, which focus on the company's investment tenets and market leadership.", "position": 0, "objective": "Why Houlihan Lokey's investment tenets matter", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "d0a554b2-3beb-4658-be5c-e2d7fd1b9f1a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slides 5-9 highlight the company's investment tenets, traction, and market leadership.", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 8, "slideType": "other", "function": "other", "notes": "The slide highlights corporate social responsibility (CSR) initiatives.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/8", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-8", "loopMatches": [ { "to": 9, "from": 5, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "77bdeb59-c138-4684-8515-17641ffd9b94", "evidence": "The golden circle loop is visible in slides 5-9, which focus on the company's investment tenets and market leadership.", "position": 0, "objective": "Why Houlihan Lokey's investment tenets matter", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "d0a554b2-3beb-4658-be5c-e2d7fd1b9f1a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slides 5-9 highlight the company's investment tenets, traction, and market leadership.", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 9, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses three side-by-side bar charts to demonstrate dominance in specific financial advisory niches.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/9", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-9", "loopMatches": [ { "to": 9, "from": 5, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "77bdeb59-c138-4684-8515-17641ffd9b94", "evidence": "The golden circle loop is visible in slides 5-9, which focus on the company's investment tenets and market leadership.", "position": 0, "objective": "Why Houlihan Lokey's investment tenets matter", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "d0a554b2-3beb-4658-be5c-e2d7fd1b9f1a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slides 5-9 highlight the company's investment tenets, traction, and market leadership.", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 10, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a series of bar charts to demonstrate market leadership across multiple verticals.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/10", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-10", "loopMatches": [ { "to": 16, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "6908d86d-676e-41e4-9c9a-d8b210c60f24", "evidence": "The quick-win-big-bet loop is visible in slides 10-16, which highlight growth opportunities and market-leading positions.", "position": 1, "objective": "How Houlihan Lokey's diversified business segments drive growth", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 10, "beatId": "2b371880-1104-4da0-8c20-c5fdeaf7c10b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 10-16 showcase the company's diversified business segments, global scale, and growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 11, "slideType": "other", "function": "analyze_data", "notes": "The slide uses donut charts to visualize revenue/business mix. The text highlights risk mitigation through low concentration (no single transaction/professional > 2%).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/11", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-11", "loopMatches": [ { "to": 16, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "6908d86d-676e-41e4-9c9a-d8b210c60f24", "evidence": "The quick-win-big-bet loop is visible in slides 10-16, which highlight growth opportunities and market-leading positions.", "position": 1, "objective": "How Houlihan Lokey's diversified business segments drive growth", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 10, "beatId": "2b371880-1104-4da0-8c20-c5fdeaf7c10b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 10-16 showcase the company's diversified business segments, global scale, and growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 12, "slideType": "geographic_map", "function": "establish_context", "notes": "The slide uses a background map to visually reinforce the global presence of the firm.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/12", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-12", "loopMatches": [ { "to": 16, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "6908d86d-676e-41e4-9c9a-d8b210c60f24", "evidence": "The quick-win-big-bet loop is visible in slides 10-16, which highlight growth opportunities and market-leading positions.", "position": 1, "objective": "How Houlihan Lokey's diversified business segments drive growth", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 10, "beatId": "2b371880-1104-4da0-8c20-c5fdeaf7c10b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 10-16 showcase the company's diversified business segments, global scale, and growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 13, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/13", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-13", "loopMatches": [ { "to": 16, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "6908d86d-676e-41e4-9c9a-d8b210c60f24", "evidence": "The quick-win-big-bet loop is visible in slides 10-16, which highlight growth opportunities and market-leading positions.", "position": 1, "objective": "How Houlihan Lokey's diversified business segments drive growth", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 10, "beatId": "2b371880-1104-4da0-8c20-c5fdeaf7c10b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 10-16 showcase the company's diversified business segments, global scale, and growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 14, "slideType": "traction", "function": "show_traction", "notes": "The slide uses two bar charts to demonstrate the correlation between headcount growth and revenue efficiency.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/14", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-14", "loopMatches": [ { "to": 16, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "6908d86d-676e-41e4-9c9a-d8b210c60f24", "evidence": "The quick-win-big-bet loop is visible in slides 10-16, which highlight growth opportunities and market-leading positions.", "position": 1, "objective": "How Houlihan Lokey's diversified business segments drive growth", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 10, "beatId": "2b371880-1104-4da0-8c20-c5fdeaf7c10b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 10-16 showcase the company's diversified business segments, global scale, and growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 15, "slideType": "timeline", "function": "show_traction", "notes": "The slide uses a two-part structure: a chronological list of service expansions and a logo-grid of acquisitions with dates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/15", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-15", "loopMatches": [ { "to": 16, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "6908d86d-676e-41e4-9c9a-d8b210c60f24", "evidence": "The quick-win-big-bet loop is visible in slides 10-16, which highlight growth opportunities and market-leading positions.", "position": 1, "objective": "How Houlihan Lokey's diversified business segments drive growth", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 10, "beatId": "2b371880-1104-4da0-8c20-c5fdeaf7c10b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 10-16 showcase the company's diversified business segments, global scale, and growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 16, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/16", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-16", "loopMatches": [ { "to": 16, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "6908d86d-676e-41e4-9c9a-d8b210c60f24", "evidence": "The quick-win-big-bet loop is visible in slides 10-16, which highlight growth opportunities and market-leading positions.", "position": 1, "objective": "How Houlihan Lokey's diversified business segments drive growth", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 10, "beatId": "2b371880-1104-4da0-8c20-c5fdeaf7c10b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 10-16 showcase the company's diversified business segments, global scale, and growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 17, "slideType": "business_model", "function": "present_framework", "notes": "The slide uses a matrix structure to compare Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/17", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 17, "beatId": "f3f852c7-de8d-42ac-8a5f-f28ef1df3af6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Competition", "beatSlug": "sequoia-pitch-competition", "evidence": "Slides 17-22 provide an overview of the business model, corporate finance, and financial restructuring.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 18, "slideType": "other", "function": "present_framework", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/18", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 17, "beatId": "f3f852c7-de8d-42ac-8a5f-f28ef1df3af6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Competition", "beatSlug": "sequoia-pitch-competition", "evidence": "Slides 17-22 provide an overview of the business model, corporate finance, and financial restructuring.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a stacked table visual to represent multiple #1 rankings across different sectors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/19", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 17, "beatId": "f3f852c7-de8d-42ac-8a5f-f28ef1df3af6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Competition", "beatSlug": "sequoia-pitch-competition", "evidence": "Slides 17-22 provide an overview of the business model, corporate finance, and financial restructuring.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 20, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a decomposition of the total M&A market to illustrate the 'Room to Grow' in the mid-cap space.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/20", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 17, "beatId": "f3f852c7-de8d-42ac-8a5f-f28ef1df3af6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Competition", "beatSlug": "sequoia-pitch-competition", "evidence": "Slides 17-22 provide an overview of the business model, corporate finance, and financial restructuring.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 21, "slideType": "other", "function": "present_solution", "notes": "Slide 21 of a pitch deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/21", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 17, "beatId": "f3f852c7-de8d-42ac-8a5f-f28ef1df3af6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Competition", "beatSlug": "sequoia-pitch-competition", "evidence": "Slides 17-22 provide an overview of the business model, corporate finance, and financial restructuring.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 22, "slideType": "traction", "function": "show_traction", "notes": "The slide uses competitive benchmarking to establish authority in the restructuring market.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/22", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 17, "beatId": "f3f852c7-de8d-42ac-8a5f-f28ef1df3af6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Competition", "beatSlug": "sequoia-pitch-competition", "evidence": "Slides 17-22 provide an overview of the business model, corporate finance, and financial restructuring.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 23, "slideType": "context", "function": "establish_context", "notes": "Includes three award badges for 2023 HFM services.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/23", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 23, "beatId": "ccad79e5-205f-48d5-aaec-37b0999c4098", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 23-30 present financial overviews, revenue breakdowns, and expense management.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 24, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a split-layout to combine qualitative value propositions with a quantitative ranking table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/24", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 23, "beatId": "ccad79e5-205f-48d5-aaec-37b0999c4098", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 23-30 present financial overviews, revenue breakdowns, and expense management.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 25, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/25", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 23, "beatId": "ccad79e5-205f-48d5-aaec-37b0999c4098", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 23-30 present financial overviews, revenue breakdowns, and expense management.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 26, "slideType": "traction", "function": "show_traction", "notes": "The slide highlights financial resilience and scalability through market cycles.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/26", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 23, "beatId": "ccad79e5-205f-48d5-aaec-37b0999c4098", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 23-30 present financial overviews, revenue breakdowns, and expense management.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 27, "slideType": "revenue_buildup", "function": "analyze_data", "notes": "The chart displays both absolute revenue figures in millions and percentage contributions per segment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/27", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 23, "beatId": "ccad79e5-205f-48d5-aaec-37b0999c4098", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 23-30 present financial overviews, revenue breakdowns, and expense management.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 28, "slideType": "other", "function": "summarize", "notes": "The slide outlines financial discipline and capital allocation priorities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/28", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 23, "beatId": "ccad79e5-205f-48d5-aaec-37b0999c4098", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 23-30 present financial overviews, revenue breakdowns, and expense management.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 29, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes detailed line items for compensation, non-compensation, operating income, other income, taxes, net income, and EPS.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/29", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 23, "beatId": "ccad79e5-205f-48d5-aaec-37b0999c4098", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 23-30 present financial overviews, revenue breakdowns, and expense management.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 30, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide presents four bar charts showing financial performance metrics over six years.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/30", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-30", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 23, "beatId": "ccad79e5-205f-48d5-aaec-37b0999c4098", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 23-30 present financial overviews, revenue breakdowns, and expense management.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 31, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a world map as a background watermark.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/31", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-31", "loopMatches": [], "arcBeatMatches": [ { "to": 32, "from": 31, "beatId": "ad80483e-e9e5-417f-a9b4-f053c6da5efe", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "The final slides highlight the company's mission and values.", "position": 5, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 32, "slideType": "mission", "function": "inspire_vision", "notes": "The slide uses a geometric design with two overlapping triangles to separate the vision and mission text.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/32", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 32, "from": 31, "beatId": "ad80483e-e9e5-417f-a9b4-f053c6da5efe", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "The final slides highlight the company's mission and values.", "position": 5, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-faf2-735b-82de-3ea74fc3e6b1", "docSlug": "bdfbc33c2af8bbda0bee5bbbc0eb9638", "documentTitle": "Houlihan Lokey | Investor Presentation Deck | 33 slides", "authorId": "houlihan-lokey", "authorName": "Houlihan Lokey", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7598534, "pageNumber": 33, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-faf2-735b-82de-3ea74fc3e6b1/33", "deckHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1", "deckAnchorHref": "/decks/019de075-faf2-735b-82de-3ea74fc3e6b1#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Includes date and ticker symbol.", "imagePath": "https://imgproxy.kitesheet.com/KhoSKt5dCgxA73wGzQWOYgitnksYcTgzjEIVQO7N4Kw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYTllYzlhYTkwYjY0MGY3OWZmNzNjMjIwYjIwZmY3ZC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/1", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "fae703f1-cd28-4418-a866-19da2c878be2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Hook", "beatSlug": "hook", "evidence": "The cover slide and executive summary grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": "https://imgproxy.kitesheet.com/RKyFqjx2xMgNfgk9svDv8MP8Na2BYvvQfRf0swZgT1c/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYTllYzlhYTkwYjY0MGY3OWZmNzNjMjIwYjIwZmY3ZC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/z22wul-ieDTPdvuchD5xikUwLsKcSDCKR07aK4UNKS8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYTllYzlhYTkwYjY0MGY3OWZmNzNjMjIwYjIwZmY3ZC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/k_80T3dRkDJRTZyoS-9Iqwya8VXRVOrwjauBcTdGxdE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYTllYzlhYTkwYjY0MGY3OWZmNzNjMjIwYjIwZmY3ZC9wMDAxLnBuZw" }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/2", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "fae703f1-cd28-4418-a866-19da2c878be2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Hook", "beatSlug": "hook", "evidence": "The cover slide and executive summary grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a numbered list format to present key value propositions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/3", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "fae703f1-cd28-4418-a866-19da2c878be2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Hook", "beatSlug": "hook", "evidence": "The cover slide and executive summary grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "pain_points", "function": "frame_problem", "notes": "Uses a hub-and-spoke diagram to illustrate the central problem of CAR-T neurotoxicity and its four primary negative impacts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/4", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-4", "loopMatches": [ { "to": 5, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c2ffc44d-9434-45d1-bdb5-742ff661b2cb", "evidence": "The pain points slide highlights the limitations of current CAR-T therapies.", "position": 0, "objective": "What is the cost of not adopting a safer CAR-T therapy?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "a9c2740d-95c0-4966-afab-fd07593c2381", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The pain points and solution slides highlight the problem and the solution.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "solution", "function": "present_solution", "notes": "Includes a cartoon mascot at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/5", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-5", "loopMatches": [ { "to": 5, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c2ffc44d-9434-45d1-bdb5-742ff661b2cb", "evidence": "The pain points slide highlights the limitations of current CAR-T therapies.", "position": 0, "objective": "What is the cost of not adopting a safer CAR-T therapy?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "a9c2740d-95c0-4966-afab-fd07593c2381", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The pain points and solution slides highlight the problem and the solution.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a bar chart combined with a data table to highlight safety advantages. It includes a disclaimer about cross-trial comparisons.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/6", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-6", "loopMatches": [ { "to": 10, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "b538a2a7-be16-4a91-b7cb-a22c4814745a", "evidence": "The competitive analysis and market sizing slides showcase the solution's advantages.", "position": 1, "objective": "Why is NXC-201 a better solution?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "4e9cfcbf-1fcc-481c-a7a9-6ab40cdca031", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "The competitive analysis and market sizing slides provide context for the solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "market_sizing", "function": "size_opportunity", "notes": "Uses icon-based visualization to represent market expansion from 5% of hospitals to a much broader network.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/7", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-7", "loopMatches": [ { "to": 10, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "b538a2a7-be16-4a91-b7cb-a22c4814745a", "evidence": "The competitive analysis and market sizing slides showcase the solution's advantages.", "position": 1, "objective": "Why is NXC-201 a better solution?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "4e9cfcbf-1fcc-481c-a7a9-6ab40cdca031", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "The competitive analysis and market sizing slides provide context for the solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "unfair_advantage", "function": "present_solution", "notes": "The slide highlights the structural difference of the NXC-201 molecule compared to Abecma, Carvykti, and CART-ddBCMA.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/8", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-8", "loopMatches": [ { "to": 10, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "b538a2a7-be16-4a91-b7cb-a22c4814745a", "evidence": "The competitive analysis and market sizing slides showcase the solution's advantages.", "position": 1, "objective": "Why is NXC-201 a better solution?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "4e9cfcbf-1fcc-481c-a7a9-6ab40cdca031", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "The competitive analysis and market sizing slides provide context for the solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "solution", "function": "present_solution", "notes": "Includes comparative bar charts and flow cytometry data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/9", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-9", "loopMatches": [ { "to": 10, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "b538a2a7-be16-4a91-b7cb-a22c4814745a", "evidence": "The competitive analysis and market sizing slides showcase the solution's advantages.", "position": 1, "objective": "Why is NXC-201 a better solution?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "4e9cfcbf-1fcc-481c-a7a9-6ab40cdca031", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "The competitive analysis and market sizing slides provide context for the solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a comparative timeline visualization to highlight the superior safety and efficacy profile of NXC-201.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/10", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-10", "loopMatches": [ { "to": 10, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "b538a2a7-be16-4a91-b7cb-a22c4814745a", "evidence": "The competitive analysis and market sizing slides showcase the solution's advantages.", "position": 1, "objective": "Why is NXC-201 a better solution?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "4e9cfcbf-1fcc-481c-a7a9-6ab40cdca031", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "The competitive analysis and market sizing slides provide context for the solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "The chart illustrates the mechanism of action and efficacy of NXC-201 (formerly HBI0101) in treating AL Amyloidosis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/11", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-11", "loopMatches": [ { "to": 16, "from": 11, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "db157f78-2fa5-4d70-8683-8c727b29e9dd", "evidence": "The traction and clinical results slides provide evidence of the solution's effectiveness.", "position": 2, "objective": "How does NXC-201 perform in clinical trials?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.8, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 16, "from": 11, "beatId": "0124f715-f9b4-4df7-a2f6-852908af15ae", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The traction and clinical results slides provide evidence of the solution's effectiveness.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a process flow diagram to illustrate the disease mechanism and a human anatomy diagram to show clinical manifestations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/12", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-12", "loopMatches": [ { "to": 16, "from": 11, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "db157f78-2fa5-4d70-8683-8c727b29e9dd", "evidence": "The traction and clinical results slides provide evidence of the solution's effectiveness.", "position": 2, "objective": "How does NXC-201 perform in clinical trials?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.8, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 16, "from": 11, "beatId": "0124f715-f9b4-4df7-a2f6-852908af15ae", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The traction and clinical results slides provide evidence of the solution's effectiveness.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a dual-metric comparison (Hematologic Response vs. Cardiac Response) to highlight NXC-201's efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/13", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-13", "loopMatches": [ { "to": 16, "from": 11, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "db157f78-2fa5-4d70-8683-8c727b29e9dd", "evidence": "The traction and clinical results slides provide evidence of the solution's effectiveness.", "position": 2, "objective": "How does NXC-201 perform in clinical trials?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.8, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 16, "from": 11, "beatId": "0124f715-f9b4-4df7-a2f6-852908af15ae", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The traction and clinical results slides provide evidence of the solution's effectiveness.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a table structure to contrast treatment efficacy and patient outcomes, with a bar chart at the bottom illustrating patient population growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/14", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-14", "loopMatches": [ { "to": 16, "from": 11, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "db157f78-2fa5-4d70-8683-8c727b29e9dd", "evidence": "The traction and clinical results slides provide evidence of the solution's effectiveness.", "position": 2, "objective": "How does NXC-201 perform in clinical trials?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.8, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 16, "from": 11, "beatId": "0124f715-f9b4-4df7-a2f6-852908af15ae", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The traction and clinical results slides provide evidence of the solution's effectiveness.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a visual comparison to highlight a 67% improvement in response rates for NXC-201 compared to competitors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/15", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-15", "loopMatches": [ { "to": 16, "from": 11, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "db157f78-2fa5-4d70-8683-8c727b29e9dd", "evidence": "The traction and clinical results slides provide evidence of the solution's effectiveness.", "position": 2, "objective": "How does NXC-201 perform in clinical trials?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.8, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 16, "from": 11, "beatId": "0124f715-f9b4-4df7-a2f6-852908af15ae", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The traction and clinical results slides provide evidence of the solution's effectiveness.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "roadmap", "function": "plan_implementation", "notes": "Includes a footer citing FDA approval precedents for similar single-arm studies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/16", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-16", "loopMatches": [ { "to": 16, "from": 11, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "db157f78-2fa5-4d70-8683-8c727b29e9dd", "evidence": "The traction and clinical results slides provide evidence of the solution's effectiveness.", "position": 2, "objective": "How does NXC-201 perform in clinical trials?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.8, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 16, "from": 11, "beatId": "0124f715-f9b4-4df7-a2f6-852908af15ae", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The traction and clinical results slides provide evidence of the solution's effectiveness.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "Includes detailed clinical trial references in the footer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/17", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-17", "loopMatches": [ { "to": 22, "from": 17, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "599f547a-a204-4d5c-892f-e80629eed470", "evidence": "The market sizing and potential slides highlight the growing opportunity.", "position": 3, "objective": "Why is now the right time for NXC-201?", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.8, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 22, "from": 17, "beatId": "411eee51-0cdb-4cef-ae47-4b4cf31a0602", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "The market sizing and potential slides help visualize the opportunity.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a two-column layout to track progress for two distinct drug programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/18", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-18", "loopMatches": [ { "to": 22, "from": 17, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "599f547a-a204-4d5c-892f-e80629eed470", "evidence": "The market sizing and potential slides highlight the growing opportunity.", "position": 3, "objective": "Why is now the right time for NXC-201?", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.8, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 22, "from": 17, "beatId": "411eee51-0cdb-4cef-ae47-4b4cf31a0602", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "The market sizing and potential slides help visualize the opportunity.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a side-by-side comparison structure to explain two distinct but complementary technology platforms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/19", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-19", "loopMatches": [ { "to": 22, "from": 17, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "599f547a-a204-4d5c-892f-e80629eed470", "evidence": "The market sizing and potential slides highlight the growing opportunity.", "position": 3, "objective": "Why is now the right time for NXC-201?", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.8, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 22, "from": 17, "beatId": "411eee51-0cdb-4cef-ae47-4b4cf31a0602", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "The market sizing and potential slides help visualize the opportunity.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a standard pharmaceutical pipeline table format.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/20", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-20", "loopMatches": [ { "to": 22, "from": 17, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "599f547a-a204-4d5c-892f-e80629eed470", "evidence": "The market sizing and potential slides highlight the growing opportunity.", "position": 3, "objective": "Why is now the right time for NXC-201?", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.8, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 22, "from": 17, "beatId": "411eee51-0cdb-4cef-ae47-4b4cf31a0602", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "The market sizing and potential slides help visualize the opportunity.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "market_sizing", "function": "size_opportunity", "notes": "Includes a comparative table of clinical outcomes (ORR/CR/sCR) for NXC-201 vs competitors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/21", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-21", "loopMatches": [ { "to": 22, "from": 17, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "599f547a-a204-4d5c-892f-e80629eed470", "evidence": "The market sizing and potential slides highlight the growing opportunity.", "position": 3, "objective": "Why is now the right time for NXC-201?", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.8, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 22, "from": 17, "beatId": "411eee51-0cdb-4cef-ae47-4b4cf31a0602", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "The market sizing and potential slides help visualize the opportunity.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a wave-like visual to represent market size, with specific dollar amounts associated with different disease categories.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/22", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-22", "loopMatches": [ { "to": 22, "from": 17, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "599f547a-a204-4d5c-892f-e80629eed470", "evidence": "The market sizing and potential slides highlight the growing opportunity.", "position": 3, "objective": "Why is now the right time for NXC-201?", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.8, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 22, "from": 17, "beatId": "411eee51-0cdb-4cef-ae47-4b4cf31a0602", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "The market sizing and potential slides help visualize the opportunity.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "transition", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/23", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 23, "beatId": "71e54a80-3feb-4065-9889-e8bc30f294b6", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The clinical highlights and proportion of patients with sCR/CR slides create desire for the solution.", "position": 5, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a red dashed box to highlight the primary efficacy metrics for comparison.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/24", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 23, "beatId": "71e54a80-3feb-4065-9889-e8bc30f294b6", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The clinical highlights and proportion of patients with sCR/CR slides create desire for the solution.", "position": 5, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The chart uses a grouped bar structure to compare NXC-201 (green) against other therapies (blue/red/grey).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/25", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 23, "beatId": "71e54a80-3feb-4065-9889-e8bc30f294b6", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The clinical highlights and proportion of patients with sCR/CR slides create desire for the solution.", "position": 5, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a red dashed box to highlight the key clinical data rows (ORR, CR, ICANS, CRS).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/26", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 23, "beatId": "71e54a80-3feb-4065-9889-e8bc30f294b6", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The clinical highlights and proportion of patients with sCR/CR slides create desire for the solution.", "position": 5, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-fb9a-714c-b35d-12bca943aee3", "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a side-by-side comparison of two disease indications, showing clinical results, relevant competitor benchmarks, and market size.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/27", "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3", "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 23, "beatId": "71e54a80-3feb-4065-9889-e8bc30f294b6", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The clinical highlights and proportion of patients with sCR/CR slides create desire for the solution.", "position": 5, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }